Arvaya Healthcare ne **October 24, 2026** ko ek board meeting bulayi hai, jisme wo **38,71,854** equity shares issue karne par faisla lenge.
Nayi Acquisition ki Taiyari
Arvaya Healthcare ne BSE ko inform kiya hai ki wo ek major strategic acquisition ki taraf badh rahe hain. October 24, 2026 ko hone wali meeting mein 38,71,854 equity shares ke allotment ko मंजूरी (approval) di ja sakti hai. Ye shares Sushodha Institute of Gastroenterology Private Limited ke shareholders ko diye jayenge.
Deal ka Twist: Cash nahi, Shares
Sabse important baat ye hai ki ye payment 'consideration other than cash' mode mein ho raha hai. Iska matlab hai ki company apna cash reserve kharch karne ki jagah naye shares issue kar rahi hai, jo ki inorganic growth ki ek classic strategy hai.
Investors ke liye kya hai?
Jab bhi company preferential basis par shares deti hai, toh equity base badh jata hai. Agle kuch dinon mein company ki taraf se filing aayegi, jisme valuation aur deal ki puri details hongi. Aapko bas ye dekhna hai ki kya ye acquisition company ki earnings mein value add karega ya sirf dilution badhayega.
Agla Step kya hoga?
Meeting ke baad aane wali official disclosure par nazar rakhein. Wahi se pata chalega ki deal ka final structure kya hai aur iska impact stock price par kaise pad sakta hai.